Rose McNulty is a Managing Editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®.
FDA Approves Third Pair of Denosumab Biosimilars
The approvals for Celltrion's denosumab-bmwo (Stoboclo and Osenvelt) mark the third FDA green light for a biosimilar to treat osteoporosis and bone metastases.
Biosimilars Regulatory Roundup: February 2025
February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.
Fresenius Kabi's Tocilizumab Biosimilar, Tyenne, Launches in US Market
Tyenne (tocilizumab-aazg) was the second tocilizumab biosimilar to be FDA approved, but it is the first to launch in the US.